From: Sent: To: Cc: Subject: - Ref.

* * 4 AmCham EU SPEAKING FOR AMERICAN BUSINESS IN EUROPE Our position Grouping of PFAS Regulation by distinct PFAS classes is scientifically superior to classification by a broad PFAS group July 2020 * AmCham EU speaks for American companies committed to Europe on trade, investment and competitiveness issues.

1 Ref.

From: Sent: To: Subject: Attachments: CAB SINKEVICIUS ARCHIVES jeudi 25 juin 2020 10:26 CAB SINKEVICIUS ARCHIVES FW: Brief summary of CSOs main points made during our meeting on 10 June 2020 CSOs priorities.pdf From: @eeb.org> Sent: Tuesday, June 23, 2020 10:43 AM To: (CAB-SINKEVICIUS) @ec.europa.eu>; (CAB-BRETON) @ec.europa.eu>; (CAB-SCHMIT) @ec.europa.eu>; (CAB-SCHMIT) @ec.europa.eu>; (CAB-KYRIAKIDES) @ec.europa.eu>; (ENER) @ec.europa.eu>; (CAB-TIMMERMANS) @ec.europa.eu>; (GROW) @ec.europa.eu>; (RTD) @ec.europa.eu>; (GROW) @ec.europa.eu>; (ENV) @ec.europa.eu>; (SG) @ec.europa.eu>; (ENV) ec.europa.eu> Cc: (BEUC - BUREAU EUROPEN DE L'UNION DES CONSOMMATEURS) @beuc.eu>; (ETUC) @etui.org> Subject: Brief summary of CSOs main points made during our meeting on 10 June 2020 Dear dear all, On behalf of BEUC, EEB and ETUC we would like to thank you again for meeting us last week and for the rich exchange on our joint policy recommendations for the future Chemicals Strategy for Sustainability within the European Green Deal.

Shin-Etsu Chemical Co., Ltd. 4-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-0005, Japan TEL: FAX: 19th, May, 2023 To: ECHA (European Chemicals Agency) Public comments by Shin-Etsu Chemical Co., Ltd (Japan) on the proposal from EU REACH to ban PFAS in materials for semiconductor production process < Contents > - About Shin-Etsu Chemical - Problematic Scope of the PFAS restriction in EU - Request of PFAS exemption for semiconductor use 1.

Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.

EUROPEAN ASSOCIATION OF PUMP MANUFACTURERS ASSOCIATION EUROPEENNE DES CONSTRUCTEURS DE POMPES EUROPAISCHE VEREINIGUNG DER PUMPENHERSTELLER Europump The Voice of the European Pump Industry SECRETARIAT Technical Commission 45 rue Louis Blanc 92400 Courbevoie - France M@europump.org Europump position on the restriction of PFAS Table of content 1.

General Comments for Annex XV restriction report on Per- and polyfluoroalkyl substances (PFAS) 22 May 2023 We welcome the opportunity to contribute to the public consultation initiated by the European Chemicals Agency regarding potential restriction of Per- and polyfluoroalkyl substances (PFAS) according to Regulation (EC) No. 1907/2006 ("REACH").

Application Number Application Name CAS RN (Candidate Substance CAS RN to be regulated) Name of Candidate Substance to be regulated Generic Name of End Product for Application Generic Name of Part for Application Description of Application (Details) Drawings, Diagrams, Photographs, Videos, etc.

Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.

Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.

Introduction MedTech Europe, the European voice of the medical technology industry including diagnostics, medical devices and (PFAS), as published in January 2023 and subject to initial exchange at ECHA's scientific committees for Risk Asse MedTech Europe is committed to the ambition of the EU Chemicals Strategy for Sustainability to boost innovation fo to improve the performance of its products and processes, including through the phase out of uses of PFAS where t PFAS in the medical technology sector Where PFAS uses occur in the medical technology sector, this is due to their unique performance and combination either in a component or coating of the final medical device (MD) or in vitro diagnostic device (IVD), including inves or as a processing aid used during device or upstream manufacturing; or in the device part of an integral drug device combination, or as cell replacement therapies, or biomaterials, PFAS substances play a key role in achieving the required high performance and durability of the technologies whic (MDs) and Regulation (EU) 2017/746 on In-Vitro Diagnostics (IVDs).

Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.

2965197 From: To: Cc: Subject: Date: Attachments: 5.1.2e MIEftcefic.be FPP4EU Sector Group answer to the 2nd Stakeholder Consultation on a Restriction for PFAS: uses of PFAS missing in the 16 Reports vrijdag 15 oktober 2021 18:21:38 FPP4EU non-exhaustive compilation of missed uses for PFAS FINAL.xlsx Dear 5.1.2e With the attached Excel sheet, we would like to contribute to the Consultation on a Restriction for PFAS, highlighting some PFAS missed uses that have been identified as having been for the compilation of the 16 Summary Reports .

Aug 1, 2023 Comment on Proposed Restriction of PFAS Japan Valve Manufacturers' Association (JVMA) Japan Valve Manufacturers' Association (JVMA) appreciates the opportunity to provide comments to the PFAS restriction proposal. 1.